ProCE Banner Activity

European Perspectives on Advances in HIV Treatment

Podcast Episodes

This podcast episode features European perspectives on some of the most important new antiretroviral therapy insights from HIV research over the past year, including findings from real-world and long-term studies of 2-drug oral regimens, the latest on 2-drug long-acting injectable therapy, and other new and emerging innovations in HIV treatment.

Released: February 17, 2023

Expiration: February 16, 2024

Share

Faculty

Alexandra Calmy

Alexandra Calmy, MD, FMH, PhD

HIV/AIDS Unit Director
Infectious Diseases Division
Geneva University Hospitals
University of Geneva
Geneva, Switzerland

Jurgen Rockstroh

Jurgen Rockstroh, MD

Head of Infectious Diseases
Professor of Medicine 
Department of Medicine I
University Hospital Bonn
Bonn, Germany  

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Alexandra Calmy, MD, FMH, PhD

HIV/AIDS Unit Director
Infectious Diseases Division
Geneva University Hospitals
University of Geneva
Geneva, Switzerland

Alexandra Calmy, MD, FMH, PhD: researcher: Gilead Sciences, Merck Sharpe and Dohme, ViiV Healthcare.

Jurgen Rockstroh, MD

Head of Infectious Diseases
Professor of Medicine 
Department of Medicine I
University Hospital Bonn
Bonn, Germany  

Jürgen K. Rockstroh, MD: consultant/advisor/speaker: Abivax, Boehringer Ingelheim, Galapagos, Gilead Sciences, Janssen, Merck, Theratechnologies, ViiV Healthcare.